You have full text access to this OnlineOpen article

Protease activated receptor 2 and the cardiovascular system

  1. Carla Cicala*

Article first published online: 29 JAN 2009

DOI: 10.1038/sj.bjp.0704438

Issue

British Journal of Pharmacology

British Journal of Pharmacology

Volume 135, Issue 1, pages 14–20, January 2002

Additional Information

How to Cite

Cicala, C. (2002), Protease activated receptor 2 and the cardiovascular system. British Journal of Pharmacology, 135: 14–20. doi: 10.1038/sj.bjp.0704438

Author Information

  1. Department of Experimental Pharmacology, University of Naples ‘Federico II’, via D. Montesano, 49 80131 Naples, Italy

*Department of Experimental Pharmacology, University of Naples ‘Federico II’, via D. Montesano, 49 80131 Naples, Italy. E-mail: cicala@unina.it

Publication History

  1. Issue published online: 29 JAN 2009
  2. Article first published online: 29 JAN 2009
  3. (Received July 19, 2001, Revised September 25, 2001, Accepted October 12, 2001)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (211K)

References

  • AKERS, I.A., PARSONS, M., HILL, M.R., HOLLENBERG, M.D., SANJAR, S., LAURENT, G.J. & MCANULTY, R.J. (2000). Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am. J. Physiol. Lung Cell. Mol. Physiol., 278, L193–L201.
  • AL-ANI, B., SAIFFEDINE, M. & HOLLENBERG, M.D. (1995). Detection of functional receptors for the proteinase-activated receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. Can. J. Physiol. Pharmacol., 73, 1203–1207.
  • ALTIERI, D.C. (1995). Xa receptor EPR-1. FASEB J., 9, 860–865.
  • BLACKHART, B.D., EMILSSON, K., NGUYEN, D., TENG, W., MARTELLI, A.J., NYSTEDT, S., SUNDELIN, J. & SCARBOROUGH, R.M. (1996). Ligand cross-reactivity within the protease activated receptor family. J. Biol. Chem., 271, 16466–16471.
  • BONE, R.C. (1992). Modulators of coagulation. A critical appraisal of their role in sepsis. Arch. Intern. Med., 152, 1381–1389.
  • BONO, F., LAMARCHE, I. & HERBERT, J.M. (1997). Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2). Biochem. Biophys. Res. Commun., 241, 762–764.
  • BONO, F., SCHAEFFER, P., HERAULT, J.P., MICHAUX, C., NESTOR, A.L., GUILLEMONT, J.C. & HERBERT, J.M. (2000). Factor Xa activates endothelial cells by a receptor cascade between EPR1 and PAR2. Arterioscler. Thromb. Vasc. Biol., 20, E107–E112.
  • CAMERER, E., ROTTINGEN, J.A., IVERSEN, J.G. & PRYDZ, H. (1996). Coagulation factor VII and X induce Ca2+ oscillations in madine-darby canine kidney cells only when proteolitically active. J. Biol. Chem., 271, 29034–29042.
  • CAMERER, E., HUANG, W. & COUGLIN, S.R. (2000). Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. U.S.A., 97, 5255–5260.
  • CHEN, J., ISHII, M., WANG, L., ISHII, K. & COUGHLIN, S.R. (1994). Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J. Biol. Chem., 269, 16041–16045.
  • CHEUNG, W., ANDRADE-GORDON, P., DERIAN, C.K. & DAMIANO, B.P. (1998). Receptor activating peptides distinguish thrombin receptor (PAR1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo. Can. J. Physiol. Pharmacol., 76, 16–25.
  • CHINNI, C., DE NIESE, M.R., JENKINS, A.L., PIKE, R.N., BOTTOMLEY, S.P. & MACKIE, E.J. (2000). Protease-activated receptor-2 mediates proliferative responses in skeletal myoblasts. J. Cell. Sci., 24, 4427–4433.
  • CICALA, C. & CIRINO, G. (1998). Linkage between inflammation and coagulation: an update on the molecular basis of the cross talk. Life Sci., 62, 1817–1824.
  • CICALA, C., PINTO, A., BUCCI, M., SORRENTINO, R., WALKER, B., HARRIOT, P., CRUCHLEY, A., KAPAS, S., HOWELLS, G. & CIRINO, G. (1999). Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circ., 99, 2590–2597.
  • CICALA, C., MORELLO, S., SANTAGADA, V., CALIENDO, G., SORRENTINO, L. & CIRINO, G. (2001). Pharmacological dissection of vascular effects caused by activation of protease-activated receptor 1 and 2 in anesthetized rats. FASEB J., 15, 1433–1435.
  • CIRINO, G., NAPOLI, C., BUCCI, M. & CICALA, C. (2000). Inflammation-coagulation network: are serine protease receptors the knot? Trends Pharmacol. Sci., 21, 170–172.
  • DAMIANO, B.P., D'ANDREA, M.R., DE GARAVILLA, L., CHEUNG, W.M. & ANDRADE-GORDON, P. (1999a). Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery. Thromb. Hemost., 81, 808–814.
  • DAMIANO, B.P., CHEUNG, W.M., SANTULLI, R.J., FUNG-LEUNG, W.P., NGO, K., YE, R.D., DARROW, A.L., DERIAN, C.K., DE GARAVILLA, L. & ANDRADE-GORDON, P. (1999b). Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther., 288, 671–678.
  • D'ANDREA, M.R., DERIAN, C.K., LETURCQ, D., BAKER, S.M., BRUNMARK, A., LING, P., DARROW, A.L., SANTULLI, R.J., BRASS, L.F. & ANDRADE GORDON, P. (1998). Characterization of protease activated receptor-2 immunoreactivity in normal human tissues. J. Hist. Cytoch., 46, 157–164.
  • DJELLAS, Y., ANTONAKIS, K. & LE BRETON, G.C. (1998). A molecular mechanism for signaling between seven transmembrane receptors: evidence for a redistribution of G proteins. Proc. Natl. Acad. Sci. U.S.A., 95, 10944–10948.
  • DERY, O., CORVERA, C.U., STEINHOFF, M. & BUNNETT, N.W. (1998). Proteinase-activated receptors: novel mechanisms of signalling by serine proteases. Am. J. Physiol., 274, C1429–C1452.
  • EMILSSON, K., WAHLESTEDT, C., SUN, M., NYSTEDT, S., OWMAN, C. & SUNDELIN, J. (1997). Vascular effects of proteinase activated receptor 2 agonist peptide. J. Vasc. Res., 34, 267–272.
  • FOX, M.T., HARRIOTT, P., WALKER, B. & STONE, S.R. (1997). Identification of potential activators of proteinase activated receptor-2. FEBS Lett., 417, 267–269.
  • GASIC, G.P., ARENAS, C.P., GASIC, T.B. & GASIC, G.J. (1992). Coagulation factor X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A., 89, 2317–2320.
  • HAMILTON, J.R. & COCKS, T.M. (2000). Heterogenous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery. Br. J. Pharmacol., 130, 181–188.
    Direct Link:
  • HAMILTON, J.R., FRAUMAN, A.G. & COCKS, T.M. (2001). Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ. Res., 89, 92–98.
  • HERBERT, J., BONO, F., HERAULT, J., AVRIL, C., DOL, F., MARES, A. & SCHAEFFER, P. (1998). Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J. Clin. Invest., 101, 993–1000.
  • HOLLENBERG, M.D., SAIFFEDINE, M. & AL-ANI, B. (1996). Proteinase activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides. Mol. Pharmacol., 49, 229–233.
  • HOLLENBERG, M.D. (1999). Protease-activated receptors: PAR4 and counting: how long is the course? Trends Pharmacol. Sci., 20, 271–273.
  • HWA, J.J., GHIBAUDI, L., WILLIAMS, P., CHINTALA, M., ZHANG, R., CHATTERJEE, M. & SYBERTZ, E. (1996). Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Cir. Res., 78, 581–588.
  • JEZIORSKA, M., MCCOLLUM, C. & WOODLEY, D.E. (1997). Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J. Pathol., 182, 115–155.
    Direct Link:
  • KAWABATA, A., KURODA, R., NAKAYA, Y., KAWAY, K., NISHIKAWA, H. & KAWAO, N. (2001). Factor Xa-evoked relaxation in rat aorta: involvement of PAR2. Biochem. Biophys. Res. Commun., 282, 432–435.
  • KO, F.N., YANG, Y.C., HUANG, S.C. & OU, J.T. (1996). Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J. Clin. Invest., 98, 1493–1501.
  • KOMURO, T., MIWA, S., OKAMOTO, Y., ENOKI, T., NINOMIYA, H., ZHANG, X.F., UEMURA, Y., KIKUCHI, H. & MASAKI, T. (1997). The involvement of a novel mechanism distinct from the thrombin receptor in the vasocontraction induced by trypsin. Br. J. Pharmacol., 120, 851–856.
    Direct Link:
  • MAGAZINE, H.I., KING, J.M. & SRIVASTAVA, K.D. (1996). Protease activated receptors modulate aortic vascular tone. Int. J. Cardiov., 53, S75–S80.
  • MIRZA, H., YATSULA, V. & BAHOU, W.F. (1996). The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J. Clin. Invest., 97, 1705–1714.
  • MOFFATT, J.D. & COCKS, T.M. (1998). Endothelium-dependent and independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries. Br. J. Pharmacol., 125, 591–594.
    Direct Link:
  • MOLINO, M., BARNATHAN, E.S., NUMEROF, R., CLARK, J., DREYER, M., CUMASHI, A., HOXIE, J., SCHECHTER, N., WOOLKALIS, M. & BROASS, L.F. (1997). Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem., 272, 4043–4049.
  • MOLINO, M., RAGHUNATAH, P.N., KUO, A., AHUJA, M., HOXIE, J.A., BRASS, L.F. & BARNATHAN, E.S. (1998). Differential expression of functional protease-activated-receptor-2 (PAR-2) in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 18, 825–832.
  • MURAMUTSU, I., LANIYONU, A.A., MOORE, G.J. & HOLLENBERG, M.D. (1992). Vascular actions of thrombin receptor peptide. Can. J. Physiol. Pharmacol., 70, 996–1003.
  • NAPOLI, C., CICALA, C., WALLACE, J.L., DE NIGRIS, F., SANTAGADA, V., CALIENDO, G., FRANCONI, F., IGNARRO, L.J. & CIRINO, G. (2000). Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc. Natl. Acad. Sci. U.S.A., 97, 3678–3683.
  • NYSTEDT, S., EMILSSON, K., WAHLESTEDT, C. & SUNDELIN, J. (1994). Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 9208–9212.
  • NYSTEDT, S., RAMAKRISHNAN, V. & SUNDELIN, J. (1996). The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J. Biol. Chem., 21, 14010–14915.
  • O'BRIEN, J.P., PREVOS, N., MOLINO, M., HOLLINGER, M.K., WOOLKALIS, M.J., WOULFE, D.S. & BRASS, L.F. (2000). Thrombin responses in human endothelial cells. J. Biol. Chem., 275, 13502–13509.
  • OHNISHI, H., SUZUKI, K., NIHO, T., ITO, C. & YAMAGUCHI, K. (1985). Protective effects of urinary trypsin inhibitor in experimental shock. Jpn. J. Pharmacol., 39, 137–144.
  • OKANO, S., TAGAWA, M., URAKAWA, N. & OGAWA, R. (1994). A therapeutic effect of ulinastatin on endotoxin-induced shock in dogs-comparison with methylprednisolone. J. Vet. Med. Sci., 56, 645–649.
  • PAPAPETROPOULOS, A., PICCARDONI, P., CIRINO, G., BUCCI, M., SORRENTINO, R., CICALA, C., JOHNSON, K., ZACHARIOU, V., SESSA, W.C. & ALTIERI, D.C. (1998). Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc. Natl. Acad. Sci. U.S.A., 95, 4738–4742.
  • RIEWALD, M. & RUF, W. (2001). Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc. Natl. Acad. Sci. U.S.A., 98, 7742–7747.
  • ROY, S., SAIFFEDINE, M., LOUTZENISHER, R., TRIGGLE, C.R. & HOLLENBERG, M.D. (1998). Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br. J. Pharmacol., 123, 1434–1440.
    Direct Link:
  • SAIFFEDINE, M., AL-ANI, B., CHENG, C.H., WANG, L. & HOLLENBERG, M.D. (1996). Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br. J. Pharmacol., 118, 521–530.
  • SAIFFEDINE, M., ROY, S.S., AL-ANI, B., TRIGGLE, C.R. & HOLLENBERG, M.D. (1998). Endothelium-dependent contractile actions of proteinase-activated receptor-2 activating peptides in human umbilical vein: release of a contracting factor via a novel receptor. Br. J. Pharmacol., 125, 1445–1454.
    Direct Link:
  • SOBEY, C.G. & COCKS, T.M. (1998). Activation of protease activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke, 29, 1439–1444.
  • SOBEY, C.G., MOFFATT, J.D. & COCKS, T.M. (1999). Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease activated receptor-2 activation. Stroke, 30, 1933–1941.
  • VU, T.K.H., HUNG, D.T., WHEATON, V.I. & COUGLIN, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057–1068.
View Full Article (HTML) Get PDF (211K)